PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.48%
Revenue growth at 50-75% of GTLB's 16.46%. Martin Whitman would worry about competitiveness or product relevance.
6.10%
Gross profit growth under 50% of GTLB's 15.13%. Michael Burry would be concerned about a severe competitive disadvantage.
-679.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-679.76%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-679.04%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-600.00%
Negative EPS growth while GTLB is at 48.39%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-600.00%
Negative diluted EPS growth while GTLB is at 48.39%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
12.45%
Share count expansion well above GTLB's 0.26%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
10.94%
Diluted share count expanding well above GTLB's 0.26%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-17.07%
Negative OCF growth while GTLB is at 89.15%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-28.39%
Negative FCF growth while GTLB is at 54.01%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
38.90%
10Y revenue/share CAGR at 50-75% of GTLB's 54.12%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
38.90%
5Y revenue/share CAGR at 50-75% of GTLB's 54.12%. Martin Whitman would worry about a lagging mid-term growth trajectory.
38.90%
3Y revenue/share CAGR at 50-75% of GTLB's 54.12%. Martin Whitman would question if the firm lags behind competitor innovations.
-20.85%
Negative 10Y OCF/share CAGR while GTLB stands at 86.41%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-20.85%
Negative 5Y OCF/share CAGR while GTLB is at 86.41%. Joel Greenblatt would question the firm’s operational model or cost structure.
-20.85%
Negative 3Y OCF/share CAGR while GTLB stands at 86.41%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-485.96%
Negative 10Y net income/share CAGR while GTLB is at 65.13%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-485.96%
Negative 5Y net income/share CAGR while GTLB is 65.13%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-485.96%
Negative 3Y CAGR while GTLB is 65.13%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
255.68%
10Y equity/share CAGR at 50-75% of GTLB's 406.36%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
255.68%
5Y equity/share CAGR at 50-75% of GTLB's 406.36%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
255.68%
3Y equity/share CAGR at 50-75% of GTLB's 406.36%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.98%
AR growth well above GTLB's 35.55%. Michael Burry fears inflated revenue or higher default risk in the near future.
48.23%
Inventory growth well above GTLB's 33.49%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
86.77%
Asset growth above 1.5x GTLB's 6.09%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
239.76%
Positive BV/share change while GTLB is negative. John Neff sees a clear edge over a competitor losing equity.
-2.72%
We’re deleveraging while GTLB stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
325.97%
R&D growth drastically higher vs. GTLB's 16.00%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
155.50%
SG&A growth well above GTLB's 19.39%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.